Third Rock Ventures, a well-known funder of Biotech startups, announced the closure of a billion-dollar fund recently that would be used to create and grow new life sciences businesses. The fund, Third Rock’s sixth, is introduced in the midst of a substantial drop in the biotech stock market, raising concerns about venture firms’ capacity to raise […]

The post Third Rock Raises Bn In Life Sciences Amid Biotech Slump first appeared on World Pharma Today.